This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eijken, M. Articles by van Leeuwen, J. P. T. M. Search for Related Content PubMed PubMed Citation Articles by Eijken, M. Articles by van Leeuwen, J. P. T. M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB DEXAMETHASONE HYDROCORTISONE Medline Plus Health Information Steroids

11ß-Hydroxysteroid Dehydrogenase Expression and Glucocorticoid Synthesis Are Directed by a Molecular Switch during Osteoblast Differentiation

Department of Internal Medicine (M.E., F.H.d.J., A.G.U., H.A.P.P., J.P.T.M.v.L.), Erasmus Medical Centre, 3000 DR Rotterdam, The Netherlands; Division of Medical Science (M.H., M.S.C., P.M.S.), Institute of Biomedical Research, The University of Birmingham, Birmingham B15 2TT, United Kingdom; and Department of Pathology (H.C.), Sapporo Medical College, Sapporo 060-8556, Japan

Address all correspondence and requests for reprints to: Dr. J. P. T. M. van Leeuwen, Erasmus Medical Center, Department Internal Medicine, Room Ee526, P.O Box 1738, 3000 DR, Rotterdam, The Netherlands. E-mail: j.vanleeuwen{at}erasmusmc.nl.

11ß-Hydroxysteroid dehydrogenase type 1 (11ß-HSD1) plays an important role in the prereceptor regulation of corticosteroids by locally converting cortisone into active cortisol. To investigate the impact of this mechanism on osteoblast development, we have characterized 11ß-HSD1 activity and regulation in a differentiating human osteoblast cell line (SV-HFO). Continuous treatment with the synthetic glucocorticoid dexamethasone induces differentiation of SV-HFO cells during 21 d of culture. Using this cell system, we showed an inverse relationship between 11ß-HSD1 activity and osteoblast differentiation. 11ß-HSD1 mRNA expression and activity were low and constant in differentiating osteoblasts. However, in the absence of differentiation (no dexamethasone), 11ß-HSD1 mRNA and activity increased strongly from d 12 of culture onward, with a peak around d 19. Promoter reporter studies provided evidence that specific regions of the 11ß-HSD1 gene are involved in this differentiation controlled regulation of the enzyme. Functional implication of these changes in 11ß-HSD1 is shown by the induction of osteoblast differentiation in the presence of cortisone. The current study demonstrates the presence of an intrinsic differentiation-driven molecular switch that controls expression and activity of 11ß-HSD1 and thereby cortisol production by human osteoblasts. This efficient mechanism by which osteoblasts generate cortisol in an autocrine fashion to ensure proper differentiation will help to understand the complex effects of cortisol on bone metabolism.

NURSA Molecule Pages Link:

Nuclear Receptors:   GR

Ligands:   Calcitriol  |  Dexamethasone  |  Hydrocortisone  |  RU486

This article has been cited by other articles:

				L. C. Hofbauer and M. Rauner Minireview: Live and Let Die: Molecular Effects of Glucocorticoids on Bone Cells Mol. Endocrinol., October 1, 2009; 23(10): 1525 - 1531. [Abstract] [Full Text] [PDF]

				M. de Mos, A. E. van der Windt, H. Jahr, H. T. M. van Schie, H. Weinans, J. A. N. Verhaar, and G. J. V. M. van Osch Can Platelet-Rich Plasma Enhance Tendon Repair?: A Cell Culture Study Am. J. Sports Med., June 1, 2008; 36(6): 1171 - 1178. [Abstract] [Full Text] [PDF]

				I J Bujalska, L L Gathercole, J W Tomlinson, C Darimont, J Ermolieff, A N Fanjul, P A Rejto, and P M Stewart A novel selective 11{beta}-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis J. Endocrinol., May 1, 2008; 197(2): 297 - 307. [Abstract] [Full Text] [PDF]

				M. Eijken, S. Swagemakers, M. Koedam, C. Steenbergen, P. Derkx, A. G. Uitterlinden, P. J. van der Spek, J. A. Visser, F. H. de Jong, H. A. P. Pols, et al. The activin A-follistatin system: potent regulator of human extracellular matrix mineralization FASEB J, September 1, 2007; 21(11): 2949 - 2960. [Abstract] [Full Text] [PDF]

				L. Stolk, J. B. J. van Meurs, M. Jhamai, P. P. Arp, J. P. T. van Leeuwen, A. Hofman, F. H. de Jong, H. A. P. Pols, and A. G. Uitterlinden The Catechol-O-Methyltransferase Met158 Low-Activity Allele and Association with Nonvertebral Fracture Risk in Elderly Men J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3206 - 3212. [Abstract] [Full Text] [PDF]

				S. Nammi, K. Dembele, and B. L. G. Nyomba Increased 11beta-hydroxysteroid dehydrogenase type-1 and hexose-6-phosphate dehydrogenase in liver and adipose tissue of rat offspring exposed to alcohol in utero Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1101 - R1109. [Abstract] [Full Text] [PDF]

				P J D Delhanty, B C J van der Eerden, M van der Velde, C Gauna, H A P Pols, H Jahr, H Chiba, A J van der Lely, and J P T M van Leeuwen Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a J. Endocrinol., January 1, 2006; 188(1): 37 - 47. [Abstract] [Full Text] [PDF]

				B. C. J. van der Eerden, J. G. J. Hoenderop, T. J. de Vries, T. Schoenmaker, C. J. Buurman, A. G. Uitterlinden, H. A. P. Pols, R. J. M. Bindels, and J. P. T. M. van Leeuwen The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption PNAS, November 29, 2005; 102(48): 17507 - 17512. [Abstract] [Full Text] [PDF]